These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7901396)

  • 1. Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency.
    Walker EA; Butelman ER; DeCosta BR; Woods JH
    J Pharmacol Exp Ther; 1993 Oct; 267(1):280-6. PubMed ID: 7901396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apparent pA2 analysis on the respiratory depressant effects of alfentanil, etonitazene, ethylketocyclazocine (EKC) and Mr2033 in rhesus monkeys.
    Butelman ER; France CP; Woods JH
    J Pharmacol Exp Ther; 1993 Jan; 264(1):145-51. PubMed ID: 8093721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys.
    Butelman ER; Negus SS; Ai Y; de Costa BR; Woods JH
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1269-76. PubMed ID: 8263790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys.
    Gerak LR; Butelman ER; Woods JH; France CP
    J Pharmacol Exp Ther; 1994 Nov; 271(2):993-9. PubMed ID: 7965822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
    Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kappa opioids in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and beta-funaltrexamine.
    Dykstra LA; Gmerek DE; Winger G; Woods JH
    J Pharmacol Exp Ther; 1987 Aug; 242(2):421-7. PubMed ID: 3302207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist and antagonist effects of dynorphin A-(1-13) in a thermal antinociception assay in rhesus monkeys.
    Butelman ER; France CP; Woods JH
    J Pharmacol Exp Ther; 1995 Oct; 275(1):374-80. PubMed ID: 7562573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the structurally novel opioid 14 alpha, 14' beta-[dithiobis [(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) on schedule-controlled behavior and thermal nociception in rhesus monkeys.
    Gatch MB; Negus SS; Mello NK; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1282-9. PubMed ID: 8819513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
    Walker EA; Makhay MM; House JD; Young AM
    J Pharmacol Exp Ther; 1994 Nov; 271(2):959-68. PubMed ID: 7965818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clocinnamox inhibits the intravenous self-administration of opioid agonists in rhesus monkeys: comparison with effects on opioid agonist-mediated antinociception.
    Zernig G; Lewis JW; Woods JH
    Psychopharmacology (Berl); 1997 Feb; 129(3):233-42. PubMed ID: 9084061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure.
    Walker EA; Zernig G; Woods JH
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1345-52. PubMed ID: 7791107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. kappa-Opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception.
    Butelman ER; Ko MC; Sobczyk-Kojiro K; Mosberg HI; Van Bemmel B; Zernig G; Woods JH
    J Pharmacol Exp Ther; 1998 May; 285(2):595-601. PubMed ID: 9580603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between mu and kappa receptor-mediated effects in opioid drug discrimination: apparent pA2 analysis.
    Bertalmio AJ; Woods JH
    J Pharmacol Exp Ther; 1987 Nov; 243(2):591-7. PubMed ID: 2824753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of heroin and its metabolites on schedule-controlled responding and thermal nociception in rhesus monkeys: sensitivity to antagonism by quadazocine, naltrindole and beta-funaltrexamine.
    Negus SS; Brandt MR; Gatch MB; Mello NK
    Drug Alcohol Depend; 2003 May; 70(1):17-27. PubMed ID: 12681522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys.
    Ko MC; Johnson MD; Butelman ER; Willmont KJ; Mosberg HI; Woods JH
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1113-20. PubMed ID: 10565831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.
    Zernig G; Butelman ER; Lewis JW; Walker EA; Woods JH
    J Pharmacol Exp Ther; 1994 Apr; 269(1):57-65. PubMed ID: 8169852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of peripheral kappa opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys.
    Ko MC; Butelman ER; Woods JH
    J Pharmacol Exp Ther; 1999 Apr; 289(1):378-85. PubMed ID: 10087027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reinforcing effect of alfentanil is mediated by mu opioid receptors: apparent pA2 analysis.
    Bertalmio AJ; Woods JH
    J Pharmacol Exp Ther; 1989 Nov; 251(2):455-60. PubMed ID: 2553919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine.
    Negus SS; Burke TF; Medzihradsky F; Woods JH
    J Pharmacol Exp Ther; 1993 Nov; 267(2):896-903. PubMed ID: 8246165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological selectivity of CTAP in a warm water tail-withdrawal antinociception assay in rats.
    Steinmiller CL; Young AM
    Psychopharmacology (Berl); 2008 Jan; 195(4):497-507. PubMed ID: 17882404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.